Baxter International (LTS:0QK8) Total Liabilities : $14,250 Mil (As of Mar. 2025)

View and export this data going back to 2014. Start your Free Trial

What is Baxter International Total Liabilities?

Baxter International's Total Liabilities for the quarter that ended in Mar. 2025 was $14,250 Mil.

Baxter International's quarterly Total Liabilities increased from Sep. 2024 ($18,734.00 Mil) to Dec. 2024 ($18,758.00 Mil) but then declined from Dec. 2024 ($18,758.00 Mil) to Mar. 2025 ($14,250.00 Mil).

Baxter International's annual Total Liabilities declined from Dec. 2022 ($22,392.00 Mil) to Dec. 2023 ($19,808.00 Mil) and declined from Dec. 2023 ($19,808.00 Mil) to Dec. 2024 ($18,758.00 Mil).

Baxter International Total Liabilities Historical Data

The historical data trend for Baxter International's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Baxter International Total Liabilities Chart

Baxter International Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

11,293.00

24,400.00

22,392.00

19,808.00

18,758.00

Baxter International Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Liabilities	Get a 7-Day Free Trial															19,553.00	18,604.00	18,734.00	18,758.00	14,250.00

Baxter International Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Baxter International's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	6511	+	(10617	+	715
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	143	+	678	+	94)
	=	18,758

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	25782	-	7024
	=	18,758

Baxter International's Total Liabilities for the quarter that ended in Mar. 2025 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	3481	+	(9647	+	1122
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	94)
	=	14,250

Total Liabilities	=	Total Assets (Q: Mar. 2025 )	-	Total Equity (Q: Mar. 2025 )
	=	21304	-	7054
	=	14,250

Baxter International Total Liabilities Related Terms

Thank you for viewing the detailed overview of Baxter International's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Baxter International Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Baxter International Inc (LTS:0QK8) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

BAX:USA BAX:Mexico 1BAX:Italy BTL:Germany BTL:Germany B1AX34:Brazil BAX:Austria

Address

One Baxter Parkway, Deerfield, IL, USA, 60015

Website

https://www.baxter.com

Baxter International Inc offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.

Baxter International Headlines

No Headlines